Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center | Zendy

Nicolas W. Shammas | Zendy; Shammas | Zendy; Nader | Zendy; Jerin | Zendy; M'Rad | Zendy; Marogil | Zendy; Pavel Dvořák | Zendy; Chintalapani | Zendy; Meriner | Zendy; Henn | Zendy

Open Access

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Author(s) -

Nicolas W. Shammas,

Shammas,

Nader,

Jerin,

M'Rad,

Marogil,

Pavel Dvořák,

Chintalapani,

Meriner,

Henn

Publication year - 2012

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s30122

Subject(s) - medicine , zotarolimus , target lesion , myocardial infarction , clinical endpoint , stent , cardiology , cohort , revascularization , surgery , thrombosis , percutaneous coronary intervention , drug eluting stent , clinical trial

In this study we compared the outcomes of the everolimus-eluting stent (EES) versus the zotarolimus-eluting stent (ZES) in patients treated at a tertiary medical center, with up to one year of follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research